Cytokinetics (CYTK) Q1 2026 Earnings

24FebConfirmed
Q2 2025
Q3 2025
Q4 2025
Q1 2026
-2.55
-2.07
-1.6
-1.12

Details

Expected EPS
-1.564384
Actual EPS
-1.5
Surprise EPS
0.06
Surprise Percent
+4.12%

Description

Cytokinetics (CYTK) has reported earnings of -1.5 per share for Q1 2026.

0 Comments

Share your thoughts